Literature DB >> 263475

Plasma concentrations of prostaglandins during late human pregnancy: influence of normal and preterm labor.

M D Mitchell, A P Flint, J Bibby, J Brunt, J M Arnold, A B Anderson, A C Turnbull.   

Abstract

Highly sensitive and specific RIA procedures have been used to measure prostaglandin concentrations in the peripheral circulation of late pregnant and parturient women. The concentrations of prostaglandin E (PGE) and prostaglandin F (PGF) in plasma samples assayed within 4 weeks of collection were not significantly different among the groups studied, the levels (mean +/- SEM, picograms per ml) were: late pregnancy (n = 13): PGE, 4.8 +/- 1.0; PGF, 6.2 +/- 0.5; early term labor (n = 5): PGE, 6.8 +/- 1.5; PGF, 7.9 +/- 0.7; late term labor (n = 5): PGE, 5.4 +/- 2.2; PGF, 12.4 +/- 3.5; and preterm labor (n = 7): PGE, 4.4 +/- 0.4; PGF, 6.9 +/- 1.4. The concentration of 13,14-dihydro-15-keto-prostaglandin F (PGFM) in late pregnancy was 59.0 +/- 7.8 pg/ml. During spontaneous term labor, the concentration of PGFM was significantly elevated (P less than 0.01) to 142.8 +/- 32.3 pg/ml in early labor and 282.7 +/- 55.3 pg/ml in late labor. The concentration of PGFM in plasma from patients in preterm labor (62.7 +/- 17.4 pg/ml) was not significantly different from that found during late pregnancy, but was significantly lower than levels found at term during early labor (P less than 0.05). The concentration of PGE increased significantly in frozen plasma samples stored for more than 4 weeks in all groups studied; the concentration of PGF was significantly elevated after storage only in the late pregnancy group (P less than 0.01). The plasma concentration of PGFM in all groups studied was unaffected by storage. It is concluded that measurement of PGFM concentrations is the most reliable method available of monitoring prostaglandins in the peripheral circulation and that great care must be exercised in the assay and interpretation of prostaglandin levels in human plasma.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 263475     DOI: 10.1210/jcem-46-6-947

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

2.  Prolactin concentrations in preterm and term pregnancy and labour.

Authors:  M Mazor; R Hershkowitz; F Ghezzi; J Cohen; W Chaim; A Wiznitzer; J Levy; J R Leiberman; M Glezerman
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

3.  Prostanoid Signaling in Cancers: Expression and Regulation Patterns of Enzymes and Receptors.

Authors:  Pavel V Ershov; Evgeniy O Yablokov; Leonid A Kaluzhskiy; Yuri V Mezentsev; Alexis S Ivanov
Journal:  Biology (Basel)       Date:  2022-04-13

4.  Effects of subarachnoid haemorrhage on intracranial prostaglandins.

Authors:  V Walker; J D Pickard; P Smythe; S Eastwood; S Perry
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-02       Impact factor: 10.154

5.  Prostaglandins in human milk.

Authors:  A Lucas; M D Mitchell
Journal:  Arch Dis Child       Date:  1980-12       Impact factor: 3.791

Review 6.  Non-narcotic analgesics. Use in pregnancy and fetal and perinatal effects.

Authors:  M A Heymann
Journal:  Drugs       Date:  1986       Impact factor: 9.546

7.  The effects of ritodrine on prostaglandin metabolite concentrations in the blood of pregnant baboons.

Authors:  G D Hankins; D M Strickland; J C Hauth; T J Kuehl; M D Mitchell
Journal:  Arch Gynecol       Date:  1983

8.  The nutritional regulation of plasma prostaglandin E concentrations in the fetus and pregnant ewe during late gestation.

Authors:  A L Fowden; R Harding; M M Ralph; G D Thorburn
Journal:  J Physiol       Date:  1987-12       Impact factor: 5.182

9.  Prostaglandins in biofluids in pregnancy and labour: A systematic review.

Authors:  Eilidh M Wood; Kylie K Hornaday; Donna M Slater
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.